We synthesized a delta opioid receptor (
DOR
) antagonist naltrindole (NTI) derivative SYK-165 with a 2,2,2-trifluoroethyl substitute on the 17-nitrogen and reported it showed
DOR
partial inverse agonist activity in [
35S] GTPγS binding assays (Bioorg. Med. Chem. Lett., 2015, 25, 2927-2930.). For the purpose of investigating the further structure-activity relationship, we designed and synthesized NTI derivatives with various electron-withdrawing groups at the 17-position to find a
DOR
full inverse agonist SYK-623, possessing a 17-cyclopropanecarbonyl group. SYK-623 was over 100-fold more potent than ICI-174,864, a standard
DOR
inverse agonist. We applied such modification to other
DOR
antagonists, 7-benzylidenenaltrexone (BNTX) and naltriben (NTB), which have respective chemotypes different from that of NTI. As a result, 17-cyclopropanecarbonyl derivatives SYK-723 (BNTX type) and SYK-724 (NTB type) were also potent
DOR
full inverse agonists. SYK-623, SYK-723, and SYK-724 are very interesting compounds because these compounds elicited potent
DOR
full inverse agonist activities in spite of the fact that they have no basic nitrogen, which is known to be indispensable functionality for the interaction with the opioid receptors.
We previously reported that opioidergic nerves system contributed to the control of cough reflex and that
DOR
antagonists induced antitussive effects (Pulm. Pharmacol. Ther., 2002, 15, 235-240.). We attempted to examine the effects of
DOR
inverse agonists on the cough reflex induced by citric acid in mice. Both SYK-623 and SYK-723 showed marked antitussive effects in a dose-dependent manner. We will report detailed results of in vitro and in vivo assays for
DOR
inverse agonists.
抄録全体を表示